Immunoglobulin Free Light Chain Dimers in Human Diseases
Immunoglobulin free light chain (FLC) kappa (κ) and lambda (λ) isotypes exist mainly in monomeric and dimeric forms. Under pathological conditions, the level of FLCs as well as the structure of monomeric and dimeric FLCs and their dimerization properties might be significantly altered. The abnormall...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1100/tsw.2011.65 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850216536486182912 |
|---|---|
| author | Batia Kaplan Avi Livneh Ben-Ami Sela |
| author_facet | Batia Kaplan Avi Livneh Ben-Ami Sela |
| author_sort | Batia Kaplan |
| collection | DOAJ |
| description | Immunoglobulin free light chain (FLC) kappa (κ) and lambda (λ) isotypes exist mainly in monomeric and dimeric forms. Under pathological conditions, the level of FLCs as well as the structure of monomeric and dimeric FLCs and their dimerization properties might be significantly altered. The abnormally high fractions of dimeric FLCs were demonstrated in the serum of patients with multiple myeloma (MM) and primary systemic amyloidosis (AL), as well as in the serum of anephric patients. The presence of tetra- and trimolecular complexes formed due to dimer-dimer and dimer-monomer interactions was detected in the myeloma serum. Analysis of the amyloidogenic light chains demonstrated mutations within the dimer interface, thus raising the possibility that these mutations are responsible for amyloidogenicity. Increased κ monomer and dimer levels, as well as a high κ/λ monomer ratio, were typically found in the cerebrospinal fluid from patients with multiple sclerosis (MS). In many MS cases, the elevation of κ FLCs was accompanied by an abnormally high proportion of λ dimers. This review focuses on the disease-related changes of the structure and level of dimeric FLCs, and raises the questions regarding their formation, function, and role in the pathogenesis and diagnosis of human diseases. |
| format | Article |
| id | doaj-art-3c2b3cf9262a4e018359ab75ce5d2e4b |
| institution | OA Journals |
| issn | 1537-744X |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-3c2b3cf9262a4e018359ab75ce5d2e4b2025-08-20T02:08:16ZengWileyThe Scientific World Journal1537-744X2011-01-011172673510.1100/tsw.2011.65Immunoglobulin Free Light Chain Dimers in Human DiseasesBatia Kaplan0Avi Livneh1Ben-Ami Sela2Heller Institute of Medical Research, Sheba Medical Center, Tel-Hashomer, IsraelHeller Institute of Medical Research, Sheba Medical Center, Tel-Hashomer, IsraelSackler School of Medicine, Tel-Aviv University, Tel-Aviv, IsraelImmunoglobulin free light chain (FLC) kappa (κ) and lambda (λ) isotypes exist mainly in monomeric and dimeric forms. Under pathological conditions, the level of FLCs as well as the structure of monomeric and dimeric FLCs and their dimerization properties might be significantly altered. The abnormally high fractions of dimeric FLCs were demonstrated in the serum of patients with multiple myeloma (MM) and primary systemic amyloidosis (AL), as well as in the serum of anephric patients. The presence of tetra- and trimolecular complexes formed due to dimer-dimer and dimer-monomer interactions was detected in the myeloma serum. Analysis of the amyloidogenic light chains demonstrated mutations within the dimer interface, thus raising the possibility that these mutations are responsible for amyloidogenicity. Increased κ monomer and dimer levels, as well as a high κ/λ monomer ratio, were typically found in the cerebrospinal fluid from patients with multiple sclerosis (MS). In many MS cases, the elevation of κ FLCs was accompanied by an abnormally high proportion of λ dimers. This review focuses on the disease-related changes of the structure and level of dimeric FLCs, and raises the questions regarding their formation, function, and role in the pathogenesis and diagnosis of human diseases.http://dx.doi.org/10.1100/tsw.2011.65 |
| spellingShingle | Batia Kaplan Avi Livneh Ben-Ami Sela Immunoglobulin Free Light Chain Dimers in Human Diseases The Scientific World Journal |
| title | Immunoglobulin Free Light Chain Dimers in Human Diseases |
| title_full | Immunoglobulin Free Light Chain Dimers in Human Diseases |
| title_fullStr | Immunoglobulin Free Light Chain Dimers in Human Diseases |
| title_full_unstemmed | Immunoglobulin Free Light Chain Dimers in Human Diseases |
| title_short | Immunoglobulin Free Light Chain Dimers in Human Diseases |
| title_sort | immunoglobulin free light chain dimers in human diseases |
| url | http://dx.doi.org/10.1100/tsw.2011.65 |
| work_keys_str_mv | AT batiakaplan immunoglobulinfreelightchaindimersinhumandiseases AT avilivneh immunoglobulinfreelightchaindimersinhumandiseases AT benamisela immunoglobulinfreelightchaindimersinhumandiseases |